Results 21 to 30 of about 1,559,737 (159)

Retrospective Study of 2-year Clinical Outcomes of Combination Ab-Interno Canaloplasty and a Microstent Compared to Ab-Interno Canaloplasty in Cataract Surgery Patients [PDF]

Clinical Ophthalmology
Valerie Trubnik,1 Lucy Huang,1 Brad Hall2 1Ophthalmic Consultants of Long Island, Manhasset, NY, USA; 2Sengi, Penniac, NB, CanadaCorrespondence: Valerie Trubnik, Ophthalmic Consultants of Long Island, 1355 Northern Boulevard, Suite 300, Manhasset, NY ...
Trubnik V, Huang L, Hall B
doaj   +2 more sources

Minimally Invasive Glaucoma Surgery (MIGS) for individuals with glaucoma. A health technology assessment [PDF]

, 2021
Key messages: This health technology assessment (HTA) summarises and supplements a 2019 Canadian HTA on the effectiveness and safety of micro-invasive glaucoma surgery (MIGS) versus other treatment options.
Lerner, Martin Robert, Reinar, Liv Merete Brynildsen, Lund, Ulrikke Højslev, Bidonde, Julia, Kvist, Beate Charlotte Fagerlund, Ursin, Lars Øystein, Kornør, Hege, Nguyen, Lien, Robberstad, Bjarne   +8 more
core   +5 more sources

Minimally Invasive Glaucoma Surgery [PDF]

, 2021
This open access book covers all aspects of minimally invasive glaucoma surgery (MIGS) and provides detailed information on each MIGS device, including its mechanism of action; patient selection; implantation techniques; post-operative management; and a ...

core   +4 more sources

Efficacy and Safety of Ab-externo Approach versus Ab-interno Approach of XEN45 Gel Stent Implantation: A Systematic Review and Meta-Analysis [PDF]

Clinical Ophthalmology
Rahaf Hubayni,1,2 Jumanah Qedair,1,2 Faisal F Aljahdali,2,3 Nawaf Alotaibi,2,3 Yasser Saleh Almuzaini,2,3 Manar M Almuntashri,2,4 Bader Alhazzaa3 1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; 2King ...
Hubayni R, Qedair J, Aljahdali FF, Alotaibi N, Almuzaini YS, Almuntashri MM, Alhazzaa B   +6 more
doaj   +2 more sources

Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye

Clinical &Experimental Ophthalmology, Volume 51, Issue 5, Page 437-445, July 2023., 2023
Abstract Background To investigate in combined iStent inject implantation with phacoemulsification carried out bilaterally, whether intraocular pressure (IOP)‐lowering effectiveness in the first eye has a predictive potential for the outcome of the second eye in primary open‐angle glaucoma (POAG).
David Kiessling, Corinna Rennings, Matthias Hild, Alexandra Lappas, Thomas S. Dietlein, Gernot F. Roessler, Randolf A. Widder   +6 more
wiley   +1 more source

Corneal Endothelial Cell Loss in Glaucoma and Glaucoma Surgery and the Utility of Management with Descemet Membrane Endothelial Keratoplasty (DMEK)

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
The corneal endothelium has a crucial role in maintaining a clear and healthy cornea. Corneal endothelial cell loss occurs naturally with age; however, a diagnosis of glaucoma and surgical intervention for glaucoma can exacerbate a decline in cell number and impairment in morphology. In glaucoma, the mechanisms for this are not well understood and this
Neeru A Vallabh, Stephnie Kennedy, Riccardo Vinciguerra, Keri McLean, Hannah Levis, Davide Borroni, Vito Romano, Colin E Willoughby, Nilufer Yesilirmak   +8 more
wiley   +1 more source

Mispositioned Hydrus Microstents: A Case Series Imaged with NIDEK GS‐1 Gonioscope

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Introduction. The Hydrus microstent has become a common procedure in glaucoma surgery intended to improve outcomes of cataract surgery to lower intraocular pressure. Despite proper placement, this device can subsequently be noted to not be in the proper position. In this case series, we report mispositioned Hydrus microstents in five different patients
Daniel Laroche, Alexander Martin, Aaron Brown, Sohail Sakkari, Chester Ng, Miguel Teus   +5 more
wiley   +1 more source

Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP‐Lowering Effect

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Purpose. The aim of the study is to assess netarsudil’s intraocular pressure (IOP)‐lowering potential when prescribed as an adjunctive agent, to examine the effect of baseline IOP on patients’ response to netarsudil, and to explore patients’ characteristics predictive of pronounced responses to netarsudil. Methods.
Sandy Samuel, Hani El Helwe, Cameron E. Neeson, Nathan Hall, Ryan Sameen Meshkin, Nino Odishelidze, Rebecca Ye, Ta C. Chang, David Solá-Del Valle, Kofi Asiedu   +9 more
wiley   +1 more source

Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies [PDF]

, 2023
Purpose: Microinvasive glaucoma surgery (MIGS) has become an important treatment approach for primary open-angle glaucoma, although the safe and long-term effective lowering of intraocular pressure with currently available implants for MIGS is not yet ...
Schmidt, Wolfram, Siewert, Stefan, Hinze, Ulf, Stiehm, Michael, Kinzel, Ludmila, Schmitz, Klaus-Peter, Grabow, Niels, Lindner, Tobias, Stahnke, Thomas, Guthoff, Rudolf F., Kischkel, Sabine, Brietzke, Andreas, Chichkov, Boris   +12 more
core   +1 more source

XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long‐Term Follow‐Up

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
This study aimed to analyze the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glaucoma. Eyes that received XEN Gel Stent placement from December 2014 to October 2019 were retrospectively investigated.
Katarzyna Lewczuk, Joanna Konopińska, Joanna Jabłońska, Jacek Rudowicz, Patrycja Laszewicz, Zofia Mariak, Marek Rękas, Giacinto Triolo   +7 more
wiley   +1 more source